Stoke Therapeutics, Inc. (STOK) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Apple Tree Partners IV, L.P. mit 17,161,713 Aktien. Weitere bedeutende Anteilseigner sind Skorpios Trust und RTW INVESTMENTS, LP.
In den letzten 12 Monaten haben Insider 55 Transaktionen in STOK Aktien getätigt — 14 Käufe (im Wert von $1.95M) und 32 Verkäufe (im Wert von $33.52M). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
STOK Insider-Beteiligungen
Größter Aktionär
Apple Tree Partners IV, L.P.
17,161,713 Aktien
Käufe (12 Monate)
14
$1.95M Wert
Verkäufe (12 Monate)
32
$33.52M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Apple Tree Partners Iv, L.p. |
10 Percent Owner |
17,161,713 |
2020-11-25 |
|
| 2 |
Skorpios Trust |
10 Percent Owner |
3,906,181 |
2025-06-06 |
|
| 3 |
Rtw Investments, Lp |
10 Percent Owner |
3,544,248 |
2019-11-12 |
|
| 4 |
Krainer Adrian R. |
Director |
283,302 |
2026-03-12 |
|
| 5 |
Smith Ian F |
Chief Executive Officer |
129,000 |
2026-02-19 |
|
| 6 |
Walker Robin A. |
Chief Legal Officer, Cco & Sec |
60,000 |
2020-03-26 |
|
| 7 |
Tulipano Stephen J |
Former CFO |
40,000 |
2024-06-07 |
|
| 8 |
Nash Huw M. |
COO & Cbo |
40,000 |
2024-06-07 |
|
| 9 |
Ticho Barry |
Chief Medical Officer |
38,864 |
2026-04-03 |
|
| 10 |
Kaye Edward M. Md |
Director |
35,500 |
2026-03-17 |
|
| 11 |
Tzianabos Arthur |
Interim Executive Chair |
31,339 |
2026-03-12 |
|
| 12 |
Burstein Jennifer |
Director |
29,747 |
2025-06-04 |
|
| 13 |
Harrison Seth Loring |
Director |
29,747 |
2025-06-04 |
|
| 14 |
Menzel Garry E |
Director |
29,747 |
2025-06-04 |
|
| 15 |
Smith Julie |
Director |
29,747 |
2025-06-04 |
|
| 16 |
Hall Samuel W. |
10 Percent Owner |
29,555 |
2019-09-12 |
|
| 17 |
Liau Gene |
EVP Research & Preclinical Dev |
21,351 |
2021-03-04 |
|
| 18 |
Allan Jonathan |
General Counsel & Corp Sec |
19,543 |
2026-03-24 |
|
| 19 |
Leggett Thomas |
Chief Financial Officer |
12,554 |
2026-03-19 |
|
| 20 |
Hoitt Jason |
Chief Patient Officer |
12,207 |
2026-03-19 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-01 |
Ticho Barry |
Chief Medical Officer |
Informierter Verkauf |
1,838 |
$32.66 |
$60.03K |
| 2026-03-20 |
Allan Jonathan |
General Counsel & Corp Sec |
Informierter Verkauf |
601 |
$34.41 |
$20.68K |
| 2026-03-18 |
Allan Jonathan |
General Counsel & Corp Sec |
Informierter Verkauf |
72 |
$32.85 |
$2.37K |
| 2026-03-17 |
Allan Jonathan |
General Counsel & Corp Sec |
Informierter Verkauf |
1,791 |
$33.38 |
$59.78K |
| 2026-03-19 |
Ticho Barry |
Chief Medical Officer |
Informierter Verkauf |
1,461 |
$29.99 |
$43.82K |
| 2026-03-18 |
Ticho Barry |
Chief Medical Officer |
Informierter Verkauf |
103 |
$32.85 |
$3.38K |
| 2026-03-17 |
Ticho Barry |
Chief Medical Officer |
Informierter Verkauf |
2,587 |
$33.38 |
$86.34K |
| 2026-03-18 |
Leggett Thomas |
Chief Financial Officer |
Informierter Verkauf |
37 |
$32.85 |
$1.22K |
| 2026-03-17 |
Leggett Thomas |
Chief Financial Officer |
Informierter Verkauf |
922 |
$33.38 |
$30.77K |
| 2026-03-18 |
Hoitt Jason |
Chief Patient Officer |
Informierter Verkauf |
30 |
$32.85 |
$985.50 |
| 2026-03-17 |
Hoitt Jason |
Chief Patient Officer |
Informierter Verkauf |
748 |
$33.38 |
$24.96K |
| 2026-03-15 |
Allan Jonathan |
General Counsel & Corp Sec |
Optionsausübung (Verkauf) |
7,475 |
- |
- |
| 2026-03-15 |
Ticho Barry |
Chief Medical Officer |
Optionsausübung (Verkauf) |
13,100 |
- |
- |
| 2026-03-15 |
Leggett Thomas |
Chief Financial Officer |
Optionsausübung |
14,750 |
- |
- |
| 2026-03-15 |
Hoitt Jason |
Chief Patient Officer |
Optionsausübung |
10,000 |
- |
- |
| 2026-03-15 |
Kaye Edward M. Md |
Director |
Optionsausübung (Verkauf) |
35,500 |
- |
- |
| 2026-03-13 |
Levin Arthur A |
Director |
Informierter Verkauf |
605 |
$36.80 |
$22.26K |
| 2026-03-10 |
Krainer Adrian R. |
Director |
Informierter Verkauf |
33,243 |
$39.74 |
$1.32M |
| 2026-03-10 |
Tzianabos Arthur |
Interim Executive Chair |
Informierter Verkauf |
4,355 |
$40.00 |
$174.21K |
| 2026-03-02 |
Krainer Adrian R. |
Director |
Informierter Verkauf |
7,229 |
$39.66 |
$286.72K |
| 2026-02-17 |
Allan Jonathan |
General Counsel & Corp Sec |
RSU-Zuteilung |
35,000 |
- |
- |
| 2026-02-17 |
Ticho Barry |
Chief Medical Officer |
RSU-Zuteilung |
40,000 |
- |
- |
| 2026-02-17 |
Leggett Thomas |
Chief Financial Officer |
RSU-Zuteilung |
40,000 |
- |
- |
| 2026-02-17 |
Hoitt Jason |
Chief Patient Officer |
RSU-Zuteilung |
48,000 |
- |
- |
| 2026-02-17 |
Smith Ian F |
Chief Executive Officer |
RSU-Zuteilung |
129,000 |
- |
- |
